- Tytuł:
- Weight loss, HbA1c reduction, and tolerability of cetilistat in a randomized, placebo-controlled phase 2 trial in obese diabetics: comparison with orlistat (Xenical)
- Autorzy:
- Źródło:
- Obesity (19307381); Jan2010, Vol. 18 Issue 1, p108-115, 8p
Czasopismo naukowe